Companies: 10,795·Total market cap: $144.5T
Neovasc Inc.

Neovasc Inc.

NVCNNASDAQHealthcare
$30.03
+$0.00(+0.00%)
Market Cap$82859377
P/E Ratio—
52W High$30.07
52W Low$4.585
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Neovasc Inc. (NVCN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001399708 · NVCN · NASDAQ · as of Jun 9, 2026

Filing snapshot

536
Total Filings
EFFECT
Latest Form
2023-08-02
Most Recent
2001
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001399708 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2022-03-10
Fiscal Year End
Mar 10, 2022
Accession No.
0001104659-22-032437
Primary Document
nvcn-20211231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001399708 · Accession 0001104659-22-032437

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2023-04-12
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2023-08-02
View
15F-12B15F-12B
15F-12B
2023-04-24
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-04-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-04-11
View
RWRW
RW
2023-04-11
View
F-10POSF-10POS
F-10POS
2023-04-11
View
POS AMPOS AM
POS AM
2023-04-11
View
S-8 POSS-8 POS
S-8 POS
2023-04-11
View
25-NSE25-NSE
25-NSE
2023-04-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-04-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-03-31
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-03-09
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-03-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-02-10
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2023-02-01
View
Showing 1–15 of 536 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001399708  |  Exchange: NASDAQ · Healthcare

Neovasc Inc. (NASDAQ: NVCN) has submitted 536 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2001. As a Healthcare sector company with CIK 0001399708, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Neovasc Inc.'s most comprehensive regulatory disclosure. The most recent Neovasc Inc. 10-K was filed on 2022-03-10 for fiscal year ending 2022. Historical NVCN 10-K annual reports are available from 2007 through 2022.

Investors researching Neovasc Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
JBIO SEC Filings →IMDX SEC Filings →ZOM SEC Filings →ASXC SEC Filings →BLI SEC Filings →IGMS SEC Filings →ZYNE SEC Filings →LFWD SEC Filings →
→ NVCN Financials→ NVCN Earnings→ NVCN Insider Trades

Frequently Asked Questions

NVCN SEC Filings · 8 questions

Neovasc Inc. (NVCN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 536 filings and access original documents at no cost. Neovasc Inc.'s CIK is 0001399708.

NVCN SEC filingsNeovasc Inc. SEC documentsfind NVCN 10-K